[ad_1]
Convention Name Members
Samuel Slutsky – LifeSci Capital, LLC, Analysis Division
Yatin Suneja – Guggenheim Securities, LLC, Analysis Division
Samantha Lynn Semenkow – Citigroup Inc. Trade Analysis
David Risinger – Leerink Companions LLC, Analysis Division
Yaron Werber – TD Cowen, Analysis Division
Yasmeen Rahimi – Piper Sandler & Co., Analysis Division
Leland Gershell – Oppenheimer & Co. Inc., Analysis Division
Douglas Tsao – H.C. Wainwright & Co, LLC, Analysis Division
Sean Kim – JPMorgan Chase & Co, Analysis Division
Georgia Calhoun
Jason Gerberry – BofA Securities, Analysis Division
Charles Ndiaye – Stifel, Nicolaus & Firm, Integrated, Analysis Division
Nathanael Charoensook – Leerink Companions LLC, Analysis Division
Corinne Jenkins – Goldman Sachs Group, Inc., Analysis Division
Presentation
Operator
Good day, and thanks for standing by. Welcome to the Immunovant Graves’ Illness Information Replace Name. [Operator Instructions] Please be suggested that at the moment’s convention is being recorded. I’d now like at hand the decision over to your first speaker at the moment, Stephanie Lee. Please go forward.
Stephanie Lee Griffin
Chief Working Officer of Roivant Platforms
Good afternoon, and thanks for becoming a member of at the moment’s name to assessment the Immunovant Graves’ illness knowledge. I am Stephanie Lee with Roivant. Presenting at the moment, we have now Matt Gline, CEO of Roivant.
For these dialing in by way of convention name, you could find the slides being introduced at the moment in addition to the press launch saying these updates on our IR web site at www.investor.roivant.com. We’ll even be offering the present slide numbers as we current that can assist you observe alongside.
I wish to remind you that we’ll be guaranteeing forward-looking statements throughout at the moment’s presentation. We strongly encourage you to assessment the data that we have now filed with the SEC for extra
[ad_2]
